Drug: IRESSA Injury: Interstitial lung disease Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
114241093 | IRESSA | Interstitial lung disease | ASTRAZENECA | 26970.00 DY | F | 52 KG | 20160922 | JP |
123764183 | IRESSA | Interstitial lung disease | BRISTOL MYERS SQUIBB | 74.00 YR | M | 0 | 20160712 | JP |
124189583 | IRESSA | Interstitial lung disease | ASTRAZENECA | 74.00 YR | F | 0 | 20160906 | JP |
125291852 | IRESSA | Interstitial lung disease | ASTRAZENECA | 90.00 YR | F | 0 | 20160722 | JP |
125559322 | IRESSA | Interstitial lung disease | ASTRAZENECA | 83.00 YR | M | 0 | 20160730 | CN |
127988771 | IRESSA | Interstitial lung disease | ASTRAZENECA | 65.00 YR | F | 70 KG | 20160930 | JP |
Total Records: 6 Number of Pages: 1